Monika L Metzger

Author PubWeight™ 43.42‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med 2009 7.95
2 Prospective medical assessment of adults surviving childhood cancer: study design, cohort characteristics, and feasibility of the St. Jude Lifetime Cohort study. Pediatr Blood Cancer 2010 2.69
3 Management of occlusion and thrombosis associated with long-term indwelling central venous catheters. Lancet 2009 2.37
4 Childhood cancer epidemiology in low-income countries. Cancer 2008 1.74
5 Pediatric cancers in the new millennium: dramatic progress, new challenges. Oncology (Williston Park) 2007 1.60
6 Treatment outcomes in black and white children with cancer: results from the SEER database and St Jude Children's Research Hospital, 1992 through 2007. J Clin Oncol 2012 1.25
7 Screening adult survivors of childhood cancer for cardiomyopathy: comparison of echocardiography and cardiac magnetic resonance imaging. J Clin Oncol 2012 1.23
8 Prevalence and predictors of abandonment of therapy among children with cancer in El Salvador. Int J Cancer 2009 1.16
9 Improved prognosis for older adolescents with acute lymphoblastic leukemia. J Clin Oncol 2010 1.16
10 Severe cardiopulmonary complications consistent with systemic inflammatory response syndrome caused by leukemia cell lysis in childhood acute myelomonocytic or monocytic leukemia. Pediatr Blood Cancer 2005 1.11
11 Methotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemia. J Clin Oncol 2014 1.10
12 Male reproductive health after childhood, adolescent, and young adult cancers: a report from the Children's Oncology Group. J Clin Oncol 2012 1.08
13 Pericardial involvement at diagnosis in pediatric Hodgkin lymphoma patients. Pediatr Blood Cancer 2007 0.96
14 Comparison of gallium and PET scans at diagnosis and follow-up of pediatric patients with Hodgkin lymphoma. Pediatr Blood Cancer 2008 0.95
15 Implementation of a data management program in a pediatric cancer unit in a low income country. Pediatr Blood Cancer 2007 0.95
16 Sperm cryopreservation practices among adolescent cancer patients at risk for infertility. Pediatr Hematol Oncol 2009 0.92
17 Thrombolytic therapy for central venous catheter occlusion. Haematologica 2011 0.92
18 Balancing efficacy and safety in the treatment of adolescents with Hodgkin's lymphoma. J Clin Oncol 2009 0.86
19 Combination chemotherapy with clofarabine, cyclophosphamide, and etoposide in children with refractory or relapsed haematological malignancies. Br J Haematol 2011 0.85
20 Comparison of treatment outcomes of childhood Hodgkin lymphoma in two US centers and a center in Recife, Brazil. Pediatr Blood Cancer 2007 0.84
21 Impact of tyrosine kinase inhibitors on minimal residual disease and outcome in childhood Philadelphia chromosome-positive acute lymphoblastic leukemia. Cancer 2014 0.84
22 Lack of specificity of plasma concentrations of inhibin B and follicle-stimulating hormone for identification of azoospermic survivors of childhood cancer: a report from the St Jude lifetime cohort study. J Clin Oncol 2013 0.82
23 Spinal epidural lipomatosis in children with hematologic malignancies. Ann Hematol 2011 0.82
24 Coronary artery disease detected by coronary computed tomography angiography in adult survivors of childhood Hodgkin lymphoma. Cancer 2014 0.81
25 Histiocyte-rich xanthomatous pseudotumor mimicking relapse on positron emission tomography imaging in an adolescent with primary mediastinal diffuse large B-cell lymphoma. J Pediatr Hematol Oncol 2012 0.80
26 Patterns of treatment failure in pediatric and young adult patients with Hodgkin's disease: local disease control with combined-modality therapy. J Clin Oncol 2005 0.80
27 ACR Appropriateness Criteria Pediatric Hodgkin Lymphoma. Pediatr Blood Cancer 2014 0.80
28 Incidence and correlates of radiation pneumonitis in pediatric patients with partial lung irradiation. Int J Radiat Oncol Biol Phys 2010 0.80
29 Itraconazole-enhanced chemotherapy toxicity in a patient with Hodgkin lymphoma. J Pediatr Hematol Oncol 2006 0.79
30 A chemotherapy only therapeutic approach to pediatric Hodgkin lymphoma: AHOPCA LH 1999. Pediatr Blood Cancer 2013 0.78
31 The role of FDG-PET/CT in the evaluation of residual disease in paediatric non-Hodgkin lymphoma. Br J Haematol 2014 0.77
32 Pediatric Hodgkin lymphoma survivors at negligible risk for significant bone mineral density deficits. Pediatr Blood Cancer 2009 0.77
33 ACR Appropriateness Criteria® Hodgkin Lymphoma-Favorable Prognosis Stage I and II. Am J Clin Oncol 2016 0.77
34 ACR Appropriateness Criteria: Localized nodal indolent lymphoma. Oncology (Williston Park) 2013 0.76
35 Watchful waiting for some children with a mediastinal mass: the potential role for ¹⁸F-fluorodeoxyglucose positron emission tomography: a case report and review of the literature. BMC Pediatr 2013 0.75
36 Utility of bone marrow biopsy at diagnosis in pediatric Hodgkin's lymphoma. Haematologica 2010 0.75
37 Relapse after treatment of pediatric Hodgkin lymphoma: outcome and role of surveillance after end of therapy. Pediatr Blood Cancer 2013 0.75
38 Genetics of pleiotropic effects of dexamethasone. Pharmacogenet Genomics 2017 0.75
39 ACR Appropriateness Criteria® Recurrent Hodgkin Lymphoma. Oncology (Williston Park) 2016 0.75
40 ACR Appropriateness Criteria® Diffuse Large B-Cell Lymphoma. Am J Clin Oncol 2015 0.75
41 ACR Appropriateness Criteria® Hodgkin Lymphoma-Unfavorable Clinical Stage I and II. Am J Clin Oncol 2016 0.75